Literature DB >> 22532536

Clinical features and genetic analysis of children with hyperekplexia in Korea.

Cha Gon Lee1, Min-Jung Kwon, Hee Joon Yu, Sook Hyun Nam, Jeehun Lee, Chang-Seok Ki, Munhyang Lee.   

Abstract

Hyperekplexia is a rare inherited neurologic disorder that is characterized by hypertonia and an exaggerated startle response to sudden external stimuli. Until now, 5 genes are known to be associated with hyperekplexia: GLRA1, SLC6A5, GLRB, GPHN, and ARHGEF9. In this report, we performed a clinical and genetic analysis of 4 Korean children with hyperekplexia. Two patients had typical clinical manifestations of hyperekplexia that initially were misdiagnosed as epilepsy. Direct sequencing of the GLRB and GLRA1 genes revealed 2 novel mutations, GLRB c.298-1G>A and c.1028C>T (p.S343F), in patient 1 and 1 novel mutation, GLRA1 c.895C>T (p.R299X), in patient 2. The other 2 familial cases, patients 3 and 4, exhibited startle responses, which appeared at the age of 1 year, and had global developmental delay. Those patients showed negative results for the 5 genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22532536     DOI: 10.1177/0883073812441058

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

1.  A novel nonsense autosomal dominant mutation in the GLRA1 gene causing hyperekplexia.

Authors:  Ivan Milenkovic; Alexander Zimprich; Martin Gencik; Kirsten Platho-Elwischger; Stefan Seidel
Journal:  J Neural Transm (Vienna)       Date:  2018-09-04       Impact factor: 3.575

2.  Impact of gold nanoparticles on brain of mice infected with Schistosoma mansoni.

Authors:  Mohamed A Dkhil; Amira A Bauomy; Marwa S M Diab; Rizwan Wahab; Denis Delic; Saleh Al-Quraishy
Journal:  Parasitol Res       Date:  2015-07-01       Impact factor: 2.289

Review 3.  Glycine receptor mouse mutants: model systems for human hyperekplexia.

Authors:  Natascha Schaefer; Georg Langlhofer; Christoph J Kluck; Carmen Villmann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

4.  Novel missense mutations in the glycine receptor β subunit gene (GLRB) in startle disease.

Authors:  Victoria M James; Anna Bode; Seo-Kyung Chung; Jennifer L Gill; Maartje Nielsen; Frances M Cowan; Mihailo Vujic; Rhys H Thomas; Mark I Rees; Kirsten Harvey; Angelo Keramidas; Maya Topf; Ieke Ginjaar; Joseph W Lynch; Robert J Harvey
Journal:  Neurobiol Dis       Date:  2012-12-10       Impact factor: 5.996

Review 5.  The impact of human hyperekplexia mutations on glycine receptor structure and function.

Authors:  Anna Bode; Joseph W Lynch
Journal:  Mol Brain       Date:  2014-01-09       Impact factor: 4.041

6.  Clinical features and genetic analysis of two siblings with startle disease in an Italian family: a case report.

Authors:  Teresa Sprovieri; Carmine Ungaro; Serena Sivo; Michela Quintiliani; Ilaria Contaldo; Chiara Veredice; Luigi Citrigno; Maria Muglia; Francesca Cavalcanti; Sebastiano Cavallaro; Eugenio Mercuri; Domenica Battaglia
Journal:  BMC Med Genet       Date:  2019-03-12       Impact factor: 2.103

7.  Novel Functional Properties of Missense Mutations in the Glycine Receptor β Subunit in Startle Disease.

Authors:  Inken Piro; Anna-Lena Eckes; Vikram Babu Kasaragod; Claudia Sommer; Robert J Harvey; Natascha Schaefer; Carmen Villmann
Journal:  Front Mol Neurosci       Date:  2021-09-24       Impact factor: 5.639

8.  Distinct phenotypes in zebrafish models of human startle disease.

Authors:  Lisa R Ganser; Qing Yan; Victoria M James; Robert Kozol; Maya Topf; Robert J Harvey; Julia E Dallman
Journal:  Neurobiol Dis       Date:  2013-09-09       Impact factor: 5.996

9.  A novel compound mutation in GLRA1 cause hyperekplexia in a Chinese boy- a case report and review of the literature.

Authors:  Zhiliang Yang; Guilian Sun; Fang Yao; Dongying Tao; Binlu Zhu
Journal:  BMC Med Genet       Date:  2017-10-06       Impact factor: 2.103

Review 10.  Impaired Glycine Receptor Trafficking in Neurological Diseases.

Authors:  Natascha Schaefer; Vera Roemer; Dieter Janzen; Carmen Villmann
Journal:  Front Mol Neurosci       Date:  2018-08-21       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.